A Study of Dabrafenib and/or Trametinib in Patients With Relapsed and/or Refractory Multiple Myeloma
NCT03091257
Age 18 +
Sex Both
Phase Phase 1
Third Opinion Trial Synopsis
Scientists are researching a new way to treat a disease called multiple myeloma. They are testing two drugs called Trametinib and Dabrafenib to see if they can help the patients who have this disease.
Scientists are researching a new way to treat a disease called multiple myeloma. They are testing two drugs called Trametinib and Dabrafenib to see if they can help the patients who have this disease.
Third Opinion AI Generated Synopsis
Trial Summary
This research study is studying a targeted therapy as a possible treatment for multiple myeloma. The names of the study drugs involved in this study are: * Trametinib * Dabrafenib
This research study is studying a targeted therapy as a possible treatment for multiple myeloma. The names of the study drugs involved in this study are: * Trametinib * Dabrafenib
from ClinicalTrials.gov
Locations & Contact
Fill out the form and to let the Multiple Myeloma Research Foundation know you are interested in this trial.
Contacts:
